Patrick Mercer - 17 Jun 2025 Form 4 Insider Report for IRIDEX CORP (IRIX)

Role
President and CEO
Signature
/s/ Nilo De Castro, Attorney-in-fact for Patrick Mercer
Issuer symbol
IRIX
Transactions as of
17 Jun 2025
Transactions value $
$66,740
Form type
4
Filing time
17 Jun 2025, 21:52:09 UTC
Previous filing
24 Jun 2025
Next filing
15 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mercer Patrick President and CEO 1212 TERRA BELLA AVENUE, MOUNTAIN VIEW /s/ Nilo De Castro, Attorney-in-fact for Patrick Mercer 17 Jun 2025 0001786824

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRIX Common Stock Award $66,740 +33,370 +8.6% $2 420,100 13 Jun 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRIX Common Stock (right to buy) Award $0 +111,240 $0 111,240 13 Jun 2025 Common Stock 111,240 $1.4 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a restricted stock unit (RSU). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest as to one-third of the shares on June 13, 2026 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 This option granted pursuant to IRIDEX Corporation's 2008 Amended and Restated Equity Incentive Plan and is exempt pursuant to Rule 16b-3.
F3 The shares are subject to vesting according to the following schedule: 1/3 of the Shares subject to the Option will vest each one-year anniversary of the date of grant.